Administered as a once-weekly injection, it aids in appetite suppression
Adverse event frequency, although not statistically different between groups, was somewhat higher in the treatment group, particularly with regard to gastrointestinal and respiratory symptoms
Hong AR, Lee J, Ku EJ, Hwangbo Y, Kim KM, Moon JH, Choi SH, Jang HC, Lim S
The widespread use of GLP-1 therapies, particularly in obesity, has raised questions about appropriate prescribing, long-term safety, and equitable access
In that context, the researchers examined the insurance claims of nearly 3,600 pregnancies among women taking GLP-1s, some of whom continued to do so during the first trimester of pregnancy and some of whom stopped
To date, the only advantage possessed by older weight loss medications is that they are often more accessible and affordable, though they are accompanied with varied side effects and decreased efficacy compared to GLP-1 and GLP/GIP medications